Citation: Mh. Robinson, IS PREOPERATIVE RADIOTHERAPY SUPERIOR TO POSTOPERATIVE RADIOTHERAPY IN THE TREATMENT OF SOFT-TISSUE SARCOMA - PRO, European journal of cancer, 34(9), 1998, pp. 1309-1311
Citation: Rb. Keus, IS PREOPERATIVE RADIOTHERAPY SUPERIOR TO POSTOPERATIVE RADIOTHERAPY IN THE TREATMENT OF SOFT-TISSUE SARCOMA - CONTRA, European journal of cancer, 34(9), 1998, pp. 1311-1314
Citation: D. Shasha et Lb. Harrison, IS PREOPERATIVE RADIOTHERAPY SUPERIOR TO POSTOPERATIVE RADIOTHERAPY IN THE TREATMENT OF SOFT-TISSUE SARCOMA - ARBITER, European journal of cancer, 34(9), 1998, pp. 1314-1316
Authors:
NEYMARK N
KIEBERT W
TORFS K
DAVIES L
FAYERS P
HILLNER B
GELBER R
GUYATT G
KIND P
MACHIN D
NORD E
OSOBA D
REVICKI D
SCHULMAN K
SIMPSON K
Citation: N. Neymark et al., METHODOLOGICAL AND STATISTICAL ISSUES OF QUALITY-OF-LIFE (QOL) AND ECONOMIC-EVALUATION IN CANCER CLINICAL-TRIALS - REPORT OF A WORKSHOP, European journal of cancer, 34(9), 1998, pp. 1317-1333
Authors:
RUITER DJ
FERRIER CM
VANMUIJEN GNP
HENZENLOGMANS SC
KENNEDY S
KRAMER MD
NIELSEN BS
SCHMITT M
Citation: Dj. Ruiter et al., QUALITY-CONTROL OF IMMUNOHISTOCHEMICAL EVALUATION OF TUMOR-ASSOCIATEDPLASMINOGEN ACTIVATORS AND RELATED COMPONENTS, European journal of cancer, 34(9), 1998, pp. 1334-1340
Authors:
SAUERBREI W
BLETTNER M
SCHMOOR C
BOJAR H
SCHUMACHER M
Citation: W. Sauerbrei et al., THE EFFECT OF ORAL-CONTRACEPTIVE USE ON THE PROGNOSIS OF NODE-POSITIVE BREAST-CANCER PATIENTS, European journal of cancer, 34(9), 1998, pp. 1348-1351
Authors:
KAWASAKI M
NAKANISHI Y
KUWANO K
TAKAYAMA K
KIYOHARA C
HARA N
Citation: M. Kawasaki et al., IMMUNOHISTOCHEMICALLY DETECTED P53 AND P-GLYCOPROTEIN PREDICT THE RESPONSE TO CHEMOTHERAPY IN LUNG-CANCER, European journal of cancer, 34(9), 1998, pp. 1352-1357
Authors:
STEVENSON JP
SCHER RM
KOSIEROWSKI R
FOX SC
SIMMONDS M
YAO KS
GREEN F
BROOM C
FIELDS SZ
KREBS JB
ODWYER PJ
Citation: Jp. Stevenson et al., PHASE-II TRIAL OF TOPOTECAN AS A 21-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED OR METASTATIC ADENOCARCINOMA OF THE PANCREAS, European journal of cancer, 34(9), 1998, pp. 1358-1362
Citation: Dja. Sonneveld et al., BILATERAL TESTICULAR GERM-CELL TUMORS IN PATIENTS WITH INITIAL-STAGE I DISEASE - PREVALENCE AND PROGNOSIS - A SINGLE CENTERS 30 YEARS EXPERIENCE, European journal of cancer, 34(9), 1998, pp. 1363-1367
Authors:
JUNGNELIUS U
RINGBORG U
AAMDAL S
MATTSSON J
STIERNER U
INGVAR C
MALMSTROM P
ANDERSSON R
KARLSSON M
WILLMAN K
WIST E
BJELKENGREN G
WESTBERG R
Citation: U. Jungnelius et al., DACARBAZINE-VINDESINE VERSUS DACARBAZINE-VINDESINE-CISPLATIN IN DISSEMINATED MALIGNANT-MELANOMA - A RANDOMIZED PHASE-III TRIAL, European journal of cancer, 34(9), 1998, pp. 1368-1374
Authors:
ESPANA F
MARTINEZ M
ROYO M
VERA CD
ESTELLES A
AZNAR J
JIMENEZCRUZ JF
Citation: F. Espana et al., LONGITUDINAL EVALUATION OF THE COMPLEXED-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IN MEN WITH PROSTATE DISEASE - EFFECT OF TREATMENT, European journal of cancer, 34(9), 1998, pp. 1375-1380
Citation: Mj. Hjermstad et al., USING REFERENCE DATA ON QUALITY-OF-LIFE - THE IMPORTANCE OF ADJUSTINGFOR AGE AND GENDER, EXEMPLIFIED BY THE EORTC QLQ-C30 (+3), European journal of cancer, 34(9), 1998, pp. 1381-1389
Authors:
ERTTMANN R
TAFESE T
BERTHOLD F
KERBL R
MANN J
PARKER L
SCHILLING F
AMBROS P
CHRISTIANSEN H
FAVROT M
KABISCH H
HERO B
PHILIP T
Citation: R. Erttmann et al., 10 YEARS NEUROBLASTOMA SCREENING IN EUROPE - PRELIMINARY-RESULTS OF ACLINICAL AND BIOLOGICAL REVIEW FROM THE STUDY-GROUP FOR EVALUATION OFNEUROBLASTOMA SCREENING IN EUROPE (SENSE), European journal of cancer, 34(9), 1998, pp. 1391-1397
Authors:
KLINGEBIEL T
BADER P
BARES R
BECK J
HERO B
JURGENS H
LANG P
NIETHAMMER D
RATH B
HANDGRETINGER R
Citation: T. Klingebiel et al., TREATMENT OF NEUROBLASTOMA STAGE 4 WITH I-131 META-IODO-BENZYLGUANIDINE, HIGH-DOSE CHEMOTHERAPY AND IMMUNOTHERAPY - A PILOT-STUDY, European journal of cancer, 34(9), 1998, pp. 1398-1402
Authors:
FERRARONI M
DECARLI A
FRANCESCHI S
LAVECCHIA C
Citation: M. Ferraroni et al., ALCOHOL-CONSUMPTION AND RISK OF BREAST-CANCER - A MULTICENTER ITALIANCASE-CONTROL STUDY, European journal of cancer, 34(9), 1998, pp. 1403-1409
Authors:
BLEYEN L
VANLANDEGHEM P
PELFRENE E
DEVRIENDT M
DESMET A
DEBACKER G
Citation: L. Bleyen et al., SCREENING FOR BREAST-CANCER IN GHENT, BELGIUM - FIRST RESULTS OF A PROGRAM INVOLVING THE EXISTING HEALTH-SERVICES, European journal of cancer, 34(9), 1998, pp. 1410-1414
Citation: F. Stenback et al., P53 EXPRESSION IN SKIN CARCINOGENESIS AND RELATIONSHIPS TO CELL-PROLIFERATION AND TUMOR-GROWTH, European journal of cancer, 34(9), 1998, pp. 1415-1424
Authors:
SCHULTZEMOSGAU MH
DALE IL
GANT TW
CHIPMAN JK
KERR DJ
GESCHER A
Citation: Mh. Schultzemosgau et al., REGULATION OF C-FOS TRANSCRIPTION BY CHEMOPREVENTIVE ISOFLAVONOIDS AND LIGNANS IN MDA-MB-468 BREAST-CANCER CELLS, European journal of cancer, 34(9), 1998, pp. 1425-1431
Authors:
CODEGONI AM
NICOLETTI MI
BURAGGI G
VALOTI G
GIAVAZZI R
DINCALCI M
LANDONI F
MANEO A
BROGGINI M
Citation: Am. Codegoni et al., MOLECULAR CHARACTERIZATION OF A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS, European journal of cancer, 34(9), 1998, pp. 1432-1438
Authors:
FUJIMOTO K
HOSOTANI R
WADA M
LEE JU
KOSHIBA T
MIYAMOTO Y
TSUJI S
NAKAJIMA S
DOI R
IMAMURA M
Citation: K. Fujimoto et al., EXPRESSION OF 2 ANGIOGENIC FACTORS, VASCULAR ENDOTHELIAL GROWTH-FACTOR AND PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR IN HUMAN PANCREATIC-CANCER, AND ITS RELATIONSHIP TO ANGIOGENESIS, European journal of cancer, 34(9), 1998, pp. 1439-1447
Authors:
WEISSLEDER R
CHENG HC
MARECOS E
KWONG K
BOGDANOV A
Citation: R. Weissleder et al., NONINVASIVE IN-VIVO MAPPING OF TUMOR VASCULAR AND INTERSTITIAL VOLUMEFRACTIONS, European journal of cancer, 34(9), 1998, pp. 1448-1454